This is a type one hybrid effectiveness-implementation study consisting of three aims. Aim one (Months 1-15) focuses on MSS enhancement using stakeholder collaboration. Aim two (Months 16-60) involves the longitudinal randomized control trial (RCT) comparing behavioral outcomes and effectiveness of enhanced MSS versus an educational webpage. Aim three (Months 16-60) will assess implementation outcomes and identify contextual factors to facilitate scale-up for future dissemination and implementation.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of primary pathologic stage 0-III cutaneous malignant melanoma
Three months to five years post-surgery
No current evidence of cancer
Not adherent to thorough SSE (i.e., did not check entire body at least once during the past three months)
≥ 18 years old
Internet access
Able to speak/read English
Able to provide informed consent
You may not be if
Children
Clareo Health | MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
